×






PieTrader

Democratizing hedge fund level analysis tools for everyone

search

(contoh: TLKM)



About
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd..

Info Profile
Name Darya-Varia Laboratoria Tbk.
Sector Healthcare
Industry Pharmaceuticals & Health Care Research
Code F2
Latest Quarterly 12/31/2024

Shareholder Tracker
Name Latest % A Month Ago %
Blue Sphere Singapore PT. Ltd 92.12 92.12
Public < 5% 7.88 7.88
Others 0.01 0.0
Shareholder Class
Classification Latest % Previous %
Institution 92.12 92.12
Retail 7.88 7.88
Individual 0.0 0.0
Management 0.0 0.0
Revenue Source 2023 2022
Consumer Health Products 50.9% 55.2%
Prescription Drugs 37.5% 33.3%
Export & Toll 10.2% 11.5%
Services 1.4% 0.0%
Others 0.0% 0.0%

Revenue Region 2023 2022
Indonesia 90.8% 89.4%
International 9.2% 10.6%
Others 0.0% 0.0%



Valuation Ratios Rank
P/S 0.81 # 5 / 15
EV_EBITDA 8.39 # 3 / 15
PER 10.60 # 4 / 15
PBV 1.17 # 4 / 15
DER 0.49 # 5 / 15

Profitability Ratios Rank
NPM % 7.5 # 6 / 15
ROA % 7.2 # 7 / 15
ROE % 10.8 # 9 / 15


Year DPS Yield [%]
2024 108.0 7.6
2023 121.0 7.3
Stock DVLA DVLA

Timeframe Performance
1W % 5.2
1Mo % -0.7
3Mo % -5.6
1Yr % 7.8

Pivot Points
R2 1610
R1 1520
S1 1335
S2 1240





Link download Laporan Keuangan emiten

Peers Comparison

Stocks PER Market Cap EV Revenue EBITDA Net Profit
DVLA 10.60 1.59 T 1.94 T 2.09 T 243 B 156 B
KLBF 17.37 55.31 T 55.45 T 32,600 B 5,070 B 3,240 B
SIDO 14.09 16.65 T 16.25 T 3,920 B 1,580 B 1,170 B
TSPC 8.02 10.82 T 9.70 T 13,700 B 2,110 B 1,450 B
SOHO 19.76 7.93 T 10.21 T 10,100 B 618 B 463 B
KAEF -4.16 2.20 T 12.80 T 10,500 B -9 B -562 B